<https://serval.unil.ch/notice/serval:BIB_1075B3F793FA#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/260952583/id> .
<https://serval.unil.ch/notice/serval:BIB_1075B3F793FA#id>	<http://purl.org/dc/elements/1.1/date>	"2017-05" .
<https://serval.unil.ch/notice/serval:BIB_1075B3F793FA#id>	<http://purl.org/ontology/bibo/doi>	"10.1016/j.thromres.2017.03.019" .
<https://serval.unil.ch/notice/serval:BIB_1075B3F793FA#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/261204823/id> .
<https://serval.unil.ch/notice/serval:BIB_1075B3F793FA#id>	<http://purl.org/dc/terms/bibliographicCitation>	"Fontana P., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Schmid P., Stricker H., Studt J.D., Tsakiris D.A., Wuillemin W.A., Nagler M.. Impact of rivaroxaban on point-of-care assays.2017." .